世界中医药
文章摘要
引用本文:徐流亮,徐笑爽.健脾化湿方治疗脾胃湿热型口腔扁平苔藓临床研究[J].世界中医药,2018,(01):.  
健脾化湿方治疗脾胃湿热型口腔扁平苔藓临床研究
Clinical Study on Jianpi Huashi Fang in the Treatment of Dampness-Heat in the Spleen and Stomach Type of Oral Lichen Planus
投稿时间:2017-01-03  
DOI:10.3969/j.issn.1673-7202.2018.01.017
中文关键词:  口腔扁平苔藓  脾胃湿热型  健脾化湿方  生命质量  免疫球蛋白  临床疗效
English Keywords:Oral lichen planus  Dampness-heat in spleen and stomach type  Jianpi Huashi Fang  Survival quality  Immunoglobulin  Clinical efficacy
基金项目:河南省科技厅科技攻关项目(152102310258)
作者单位
徐流亮,徐笑爽 开封大学医学部开封475000 
摘要点击次数: 1422
全文下载次数: 1697
中文摘要:
      目的:观察健脾化湿方治疗脾胃湿热型口腔扁平苔藓的临床疗效。方法:选取2015年8月至2016年7月开封大学医学部收治的脾胃湿热型口腔扁平苔藓患者124例,随机分为观察组与对照组,每组62例。对照组患者采用转移因子胶囊治疗,观察组患者采用健脾化湿方治疗。比较2组治疗前后中医症候积分、生命质量、免疫球蛋白A(Immunoglobulin A,IgA)、免疫球蛋白G(Immunoglobulin G,IgG)、免疫球蛋白M(Immunoglobulin M,IgM)值及不良反应的发生情况,并对2组临床疗效进行评价。结果:与治疗前比较,观察组与对照组中医症候积分、IgG、IgM在治疗后均下降,而生命质量评分均上升,且观察组上述观察指标均优于对照组,差异有统计学意义(P<0.05);与治疗前比较,观察组与对照组IgA在治疗后比较,差异无统计学意义(P>0.05);观察组临床疗效总有效率、不良反应发生率分别为88.71%(55/62)、3.23%(2/62),均优于对照组74.19%(46/62)、19.35%(12/62),差异有统计学意义(P<0.05)。结论:对脾胃湿热型口腔扁平苔藓患者采用健脾化湿方治疗,可显著提高临床疗效,缓解临床症状,改善免疫球蛋白水平,促进患者身体恢复,提高生命质量,且不良反应少,具有临床推广意义。
English Summary:
      To observe the clinical efficacy of Jianpi Huashi Fang in the treatment of dampness-heat in spleen and stomach type of oral lichen planus (OLP). Methods:A total of 124 patients with dampness-heat in spleen and stomach type of OLP who were treated in our hospital from August 2015 to July 2016 were randomly divided into control group and research group, with 62 cases in each. Control group took transfer factor capsules, and research group took Jianpi Huashi Fang. The TCM symptom score, survival quality, immunoglobulin (immunoglobulin A (IgA), immunoglobulin G (IgG), immunoglobulin M (IgM)) values, adverse reactions of 2 groups before and after treatment were compared, and clinical efficacy of two groups were evaluated. Results:Compared with pre-treatment, the TCM symptom score, IgG, IgM of 2 groups decreased after treatment, but survival quality scores increased, and above indexes of research group were better than control group (P<0.05); Compared with pre-treatment, the IgA of two groups had no significant difference after treatment (P>0.05); The total effective rate, incidence of adverse reactions in research group were 88.71% (55/62), 3.23% (2/62) respectively, which were better than 74.19% (46/62), 19.35% (12/62) of control group (P<0.05). Conclusion:Jianpi Huashi therapy for treating dampness-heat in spleen and stomach type of OLP can significantly increase clinical efficacy, relieve clinical symptoms, improve immunoglobulin level, promote body recovery, increase survival quality and have less adverse reactions, which has significance of clinical promotion.
查看全文  查看/发表评论  下载PDF阅读器